Literature DB >> 15984982

Infusion of neostigmine-glycopyrrolate for bowel evacuation in persons with spinal cord injury.

Mark A Korsten1, Alan S Rosman, Anthony Ng, Erdal Cavusoglu, Ann M Spungen, Miroslav Radulovic, Jill Wecht, William A Bauman.   

Abstract

Defecatory complications are common after spinal cord injury (SCI) and have been attributed, in part, to an imbalance of the autonomic nervous system between parasympathetic and sympathetic effects on the colon. Because parasympathetic (i.e., cholinergic) input to the bowel may be downregulated after SCI, it was hypothesized that neostigmine, a medication that increases cholinergic tone by blocking the metabolism of acetylcholine, might promote bowel evacuation in these persons. Since neostigmine is known to cause bradycardia and bronchoconstriction, we also assessed whether these side-effects could be prevented by coadministration of neostigmine with glycopyrrolate, an anticholinergic agent that has limited activity on the muscarinic receptors of the colon. The hypothesis was tested in 13 persons with SCI in whom videofluoroscopy was carried out after instillation of a barium oatmeal paste into the rectum and descending colon. On separate days, subjects received, in a randomized, blinded design, one of three intravenous infusates (normal saline, 2 mg neostigmine, or 2 mg neostigmine + 0.4 mg glycopyrrolate). The effect of these infusates on bowel evacuation of the barium paste, heart rate, and airway resistance was determined. Both neostigmine and neostigmine + glycopyrrolate resulted in prompt bowel evacuation. The nadir heart rate was lower after neostigmine alone than with the combination. Neostigmine administration increased both total and central airway resistance, an effect that was not observed with the coadministration of glycopyrrolate. Other side-effects of neostigmine and the combination of drugs included muscle fasciculations and dry mouth, both of which were mild and short-lived. Abdominal cramping was noted in subjects with spinal cord lesions below thoracic level 10. These results indicated that neostigmine/glycopyrrolate administration is safe and well tolerated in persons with chronic SCI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15984982     DOI: 10.1111/j.1572-0241.2005.41587.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Neurogenic Bowel Dysfunction in Patients with Neurogenic Bladder.

Authors:  Laura Martinez; Leila Neshatian; Rose Khavari
Journal:  Curr Bladder Dysfunct Rep       Date:  2016-10-20

Review 2.  Neurogenic bowel management after spinal cord injury: a systematic review of the evidence.

Authors:  A Krassioukov; J J Eng; G Claxton; B M Sakakibara; S Shum
Journal:  Spinal Cord       Date:  2010-03-09       Impact factor: 2.772

Review 3.  Neural pathways for colorectal control, relevance to spinal cord injury and treatment: a narrative review.

Authors:  Brid Callaghan; John B Furness; Ruslan V Pustovit
Journal:  Spinal Cord       Date:  2017-11-16       Impact factor: 2.772

Review 4.  Bowel Dysfunction in Spinal Cord Injury.

Authors:  Zhengyan Qi; James W Middleton; Allison Malcolm
Journal:  Curr Gastroenterol Rep       Date:  2018-08-29

5.  Pharmacokinetics of the ghrelin agonist capromorelin in a single ascending dose Phase-I safety trial in spinal cord-injured and able-bodied volunteers.

Authors:  A G Ellis; P T Zeglinski; D J Brown; A G Frauman; M Millard; J B Furness
Journal:  Spinal Cord       Date:  2014-12-02       Impact factor: 2.772

Review 6.  Cardiovascular effects of noncardiovascular drugs.

Authors:  Satish R Raj; C Michael Stein; Pablo J Saavedra; Dan M Roden
Journal:  Circulation       Date:  2009-09-22       Impact factor: 29.690

7.  31st g. Heiner sell lectureship: secondary medical consequences of spinal cord injury.

Authors:  William A Bauman; Mark A Korsten; Miroslav Radulovic; Gregory J Schilero; Jill M Wecht; Ann M Spungen
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

8.  Comparison between pulsed irrigation enhanced evacuation and polyethylene glycol-electrolyte lavage solution for bowel preparation prior to elective colonoscopy in veterans with spinal cord injury.

Authors:  Brian L Lyons; Mark A Korsten; Ann M Spungen; Miroslav Radulovic; Alan S Rosman; Kristel Hunt; Marinella D Galea; Stephen D Kornfeld; Christina Yen; William A Bauman
Journal:  J Spinal Cord Med       Date:  2014-08-06       Impact factor: 1.985

9.  Intramuscular neostigmine and glycopyrrolate safely accelerated bowel evacuation in patients with spinal cord injury and defecatory disorders.

Authors:  Alan S Rosman; Geeta Chaparala; Amit Monga; Ann M Spungen; William A Bauman; Mark A Korsten
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

10.  Neostigmine and glycopyrronium: a potential safe alternative for patients with pseudo-obstruction without access to conventional methods of decompression.

Authors:  Alfred Adiamah; Sarah Johnson; Adrian Ho; James Orbell
Journal:  BMJ Case Rep       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.